BRPI0414059A - sìntese seletiva de pirimidinas substituìdas em cf3 - Google Patents

sìntese seletiva de pirimidinas substituìdas em cf3

Info

Publication number
BRPI0414059A
BRPI0414059A BRPI0414059-1A BRPI0414059A BRPI0414059A BR PI0414059 A BRPI0414059 A BR PI0414059A BR PI0414059 A BRPI0414059 A BR PI0414059A BR PI0414059 A BRPI0414059 A BR PI0414059A
Authority
BR
Brazil
Prior art keywords
formula
selective synthesis
compound
substituted pyrimidines
substituted
Prior art date
Application number
BRPI0414059-1A
Other languages
English (en)
Inventor
John Charles Kath
Daniel Tyler Richter
Michael Joseph Luzzio
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0414059A publication Critical patent/BRPI0414059A/pt
Publication of BRPI0414059B1 publication Critical patent/BRPI0414059B1/pt
Publication of BRPI0414059B8 publication Critical patent/BRPI0414059B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"SìNTESE SELETIVA DE PIRIMIDINAS SUBSTITUìDAS EM CF3". A presente invenção refere-se com um método de preparar um composto de fórmula (I) em que X¬ 1¬, X¬ 2¬ e R¬ 3¬ -R¬ 4¬ são como aqui definido. O método inclui reagir um composto de fórmula (II) com uma amina de fórmula (III) (HNR¬ 3¬R¬ 4¬) na presença de um ácido de Lewis e uma base não-nucleófila. A porção 2,4-diaminopirimidina é um componente comum em várias moléculas semelhantes a fármaco biologicamente ativas e verificou-se que derivados de pirimidina são úteis no tratamento de crescimento celular anormal, tal como câncer, em mamíferos.
BRPI0414059A 2003-09-05 2004-08-24 síntese seletiva de pirimidinas substituídas em cf3 BRPI0414059B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50073303P 2003-09-05 2003-09-05
US60/500,733 2003-09-05
PCT/IB2004/002744 WO2005023780A1 (en) 2003-09-05 2004-08-24 Selective synthesis of cf3-substituted pyrimidines

Publications (3)

Publication Number Publication Date
BRPI0414059A true BRPI0414059A (pt) 2006-10-24
BRPI0414059B1 BRPI0414059B1 (pt) 2018-11-06
BRPI0414059B8 BRPI0414059B8 (pt) 2021-05-25

Family

ID=34272990

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414059A BRPI0414059B8 (pt) 2003-09-05 2004-08-24 síntese seletiva de pirimidinas substituídas em cf3

Country Status (23)

Country Link
US (1) US7122670B2 (pt)
EP (1) EP1663991B1 (pt)
JP (1) JP4842816B2 (pt)
KR (1) KR100694732B1 (pt)
CN (1) CN100465164C (pt)
AR (1) AR045557A1 (pt)
BR (1) BRPI0414059B8 (pt)
CA (1) CA2537373C (pt)
CO (1) CO5650237A2 (pt)
CY (1) CY1106370T1 (pt)
DE (1) DE602004004287T2 (pt)
DK (1) DK1663991T3 (pt)
ES (1) ES2276344T3 (pt)
IL (1) IL173363A (pt)
MX (1) MXPA06002552A (pt)
NO (1) NO334383B1 (pt)
NZ (1) NZ544969A (pt)
PL (1) PL1663991T3 (pt)
PT (1) PT1663991E (pt)
RU (1) RU2315759C2 (pt)
TW (1) TWI283667B (pt)
WO (1) WO2005023780A1 (pt)
ZA (1) ZA200600747B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH072586Y2 (ja) 1988-11-25 1995-01-25 日東紡績株式会社 ガラス繊維紡糸用冷却フィン装置
EA013248B1 (ru) * 2002-12-20 2010-04-30 Пфайзер Продактс Инк. Производные пиримидина для лечения патологического роста клеток
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
JP4778717B2 (ja) * 2005-03-25 2011-09-21 富士フイルム株式会社 複素環式化合物の製造方法
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
AP2009005010A0 (en) 2007-04-18 2009-10-31 Pfizer Prod Inc Sulfonyl amide derivatives for the treatment of abnormal cell growth
KR101294731B1 (ko) * 2007-06-04 2013-08-16 삼성디스플레이 주식회사 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법
UY31714A (es) * 2008-03-20 2009-11-10 Boehringer Ingelheim Int Preparación selectiva de pirimidinas sustituidas
EP2268621A1 (en) * 2008-03-20 2011-01-05 Boehringer Ingelheim International GmbH Regioselective preparation of substituted pyrimidines
DE102009006643A1 (de) * 2009-01-29 2010-08-05 Saltigo Gmbh Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten
TW201100441A (en) * 2009-06-01 2011-01-01 Osi Pharm Inc Amino pyrimidine anticancer compounds
US8933227B2 (en) * 2009-08-14 2015-01-13 Boehringer Ingelheim International Gmbh Selective synthesis of functionalized pyrimidines
JP5539518B2 (ja) * 2009-08-14 2014-07-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ２−アミノ−５−トリフルオロメチルピリミジン誘導体の位置選択的調製
JP6000273B2 (ja) 2010-11-29 2016-09-28 オーエスアイ・ファーマシューティカルズ，エルエルシー 大環状キナーゼ阻害剤
UY33817A (es) 2010-12-21 2012-07-31 Boehringer Ingelheim Int ?nuevas oxindolpirimidinas bencílicas?.
AU2012216894B2 (en) 2011-02-17 2016-07-14 Cancer Therapeutics Crc Pty Limited Selective FAK inhibitors
US20130324532A1 (en) 2011-02-17 2013-12-05 Cancer Therapeutics Crc Pty Limited Fak inhibitors
WO2014126954A1 (en) 2013-02-13 2014-08-21 OSI Pharmaceuticals, LLC Regioselective synthesis of substituted pyrimidines
WO2015170600A1 (ja) 2014-05-08 2015-11-12 東ソー・エフテック株式会社 ５－（トリフルオロメチル）ピリミジン誘導体及びその製造方法
JP6391985B2 (ja) * 2014-05-16 2018-09-19 東ソー・ファインケム株式会社 ２−置換−４−（２，２，２−トリフルオロエトキシ）−５−（トリフルオロメチル）ピリミジン誘導体及びその製造方法
JP6391988B2 (ja) * 2014-05-21 2018-09-19 東ソー・ファインケム株式会社 ５−（トリフルオロメチル）ピリミジン誘導体の製造方法及び新規５−（トリフルオロメチル）ピリミジン誘導体
CN108440499A (zh) * 2018-03-22 2018-08-24 盐城师范学院 一种色瑞替尼及其关键中间体的制备方法
CN114213339B (zh) * 2021-12-20 2023-10-31 苏州康纯医药科技有限公司 一种表皮细胞生长因子受体突变抑制剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688087B2 (en) * 1994-08-13 1998-03-05 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
DK1438053T3 (da) * 2001-10-17 2008-12-08 Boehringer Ingelheim Pharma Pyrimidinderivater, lægemiddel indeholdende disse forbindelser, deres anvendelse og fremgangsmåder til deres fremstilling

Also Published As

Publication number Publication date
CA2537373A1 (en) 2005-03-17
TW200514773A (en) 2005-05-01
AR045557A1 (es) 2005-11-02
IL173363A (en) 2010-05-31
JP4842816B2 (ja) 2011-12-21
HK1091824A1 (zh) 2007-01-26
PT1663991E (pt) 2007-02-28
EP1663991B1 (en) 2007-01-10
IL173363A0 (en) 2006-06-11
NZ544969A (en) 2008-07-31
JP2007504211A (ja) 2007-03-01
DK1663991T3 (da) 2007-04-10
BRPI0414059B1 (pt) 2018-11-06
PL1663991T3 (pl) 2007-04-30
KR20060030918A (ko) 2006-04-11
CA2537373C (en) 2009-10-20
MXPA06002552A (es) 2006-06-20
CN1845906A (zh) 2006-10-11
BRPI0414059B8 (pt) 2021-05-25
US20050101620A1 (en) 2005-05-12
US7122670B2 (en) 2006-10-17
AU2004270480A1 (en) 2005-03-17
RU2315759C2 (ru) 2008-01-27
WO2005023780A1 (en) 2005-03-17
TWI283667B (en) 2007-07-11
NO20061509L (no) 2006-04-03
RU2006106727A (ru) 2006-06-27
CO5650237A2 (es) 2006-06-30
DE602004004287T2 (de) 2007-06-21
NO334383B1 (no) 2014-02-24
EP1663991A1 (en) 2006-06-07
DE602004004287D1 (de) 2007-02-22
CN100465164C (zh) 2009-03-04
ZA200600747B (en) 2007-03-28
ES2276344T3 (es) 2007-06-16
CY1106370T1 (el) 2011-10-12
KR100694732B1 (ko) 2007-03-14

Similar Documents

Publication Publication Date Title
BRPI0414059B8 (pt) síntese seletiva de pirimidinas substituídas em cf3
DE502004005772D1 (de) Verfahren zur herstellung von 3-phenyl(thio)uracilen und 3-phenyldithiouracilen
MY142109A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
DE60211343D1 (de) Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente
TW200612949A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
NO20082338L (no) Pyrimidinderivater for behandling av avvikende cellevekst
TW200607801A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
TW200740805A (en) Novel compounds
BR0316470A (pt) Derivados de 3-amino-piperadina e métodos de preparação
IN2006DE01793A (pt)
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
NZ596025A (en) [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
BRPI0416690A (pt) derivados de pirrol
CY1106677T1 (el) Παρασκευη ν1-(2’-πυριδυλ)-1, 2-προπανοδιαμινο σουλφαμικου οξεος και χρηση αυτου στη συνθεση βιολογικως δραστικων πιπεραζινων
MY138051A (en) Compounds and processes
SG158864A1 (en) Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1- carboxylic acid derivatives and related compounds
BRPI0511138A (pt) derivados de pirimidina para o tratamento de desenvolvimento celular anormal
DE602004031115D1 (de) Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
ATE332336T1 (de) Azoverbindungen
ITMI20020933A1 (it) Procedimento per la sintesi di clopidogrel
IL183805A0 (en) Process for preparing substituted thiophenesulfonyl isocyanates
BRPI0416377A (pt) processo para a sìntese de imidazóis
MX2007004638A (es) Proceso para la preparacion de pirazoles.
BRPI0416663A (pt) processos para a preparação de ftalimidas n-substituìdas
DK0504290T3 (da) Inhibitorer af dihydrofylatreduktase fra Pneumocystis carinii

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: "PARA: INT. CL. C07D 239/42

Ipc: C07D 239/42 (2011.01), A61P 35/00 (2011.01)

Free format text: PARA: INT. CL. C07D 239/42; A61P 35/00

Ipc: C07D 239/42 (2011.01), A61P 35/00 (2011.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/11/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/08/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2844 DE 08-07-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.